Chemical Component Summary

Name5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
SynonymsPQR309
Identifiers5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
FormulaC17 H20 F3 N7 O2
Molecular Weight411.38
TypeNON-POLYMER
Isomeric SMILESc1c(c(cnc1N)c2nc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
InChIInChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)
InChIKeyADGGYDAFIHSYFI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count49
Chiral Atom Count0
Bond Count52
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB14846 
NameBimiralisib
Groupsinvestigational
DescriptionBimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)).
SynonymsBimiralisib
CAS number1225037-39-7

Related Resource References

Resource NameReference
PubChem58507717
ChEMBLCHEMBL4084907